Synthetic Drug Awareness Act of 2018

Bill: 115-s-3356
Sponsor: full_name: Sen. Hassan, Margaret Wood [D-NH]
Introduced: 2018-08-21
Policy area: Health
Latest action: action_date: 2018-08-21
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2018-08-21
action_desc: Introduced in Senate
text: <p><b>Synthetic Drug Awareness Act of </b><b>2018</b></p> <p>This bill requires the Surgeon General to report to Congress on the health effects of new psychoactive substances (e.g., synthetic marijuana), specifically those used since January 2010 by individuals who are 12 to 18 years old. </p>

tv_txt: II 115th CONGRESS 2d Session S. 3356 IN THE SENATE OF THE UNITED STATES August 21, 2018 Ms. Hassan (for herself, Mr. Cassidy , Mr. Jones , and Mr. Young ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To require the Surgeon General of the Public Health Service to submit to Congress a report on the health effects of new psychoactive substances (including synthetic drugs) use.

1. Short title This Act may be cited as the Synthetic Drug Awareness Act of 2018 . 2. Report on effects on public health of synthetic drug use (a) In general Not later than 3 years after the date of the enactment of this Act, the Surgeon General of the Public Health Service shall submit to Congress a report on the health effects of new psychoactive substances (including synthetic drugs) used since January 2010 by persons who are at least 12 years of age but no more than 18 years of age. (b) New psychoactive substance defined For purposes of subsection (a), the term new psychoactive substance means a controlled substance analogue (as defined in section 102(32) of the Controlled Substances Act ( 21 U.S.C. 802(32) )).